Iovance Biotherapeutics IOVA
NASDAQ IOVA
$7.70 -0.39 (-4.84%)
As of: Nov 12, 2026 · 10:49 AM EST

Iovance Biotherapeutics (IOVA) Return on Capital Employed [ROCE] (2010 - 2026)

Updated

Iovance Biotherapeutics (IOVA) reported Return on Capital Employed [ROCE] of -37.03% for Q2 2026, up 13.80 percentage points from -50.83% a year earlier and up 8.94 percentage points from the prior quarter.

Analysis

Iovance Biotherapeutics (IOVA) Return on Capital Employed [ROCE] (2010 - 2026) Analysis & Trends

For FY2025, Iovance Biotherapeutics posted Return on Capital Employed [ROCE] of -52.15%, up 2.52 percentage points from FY2024.

  • Return on Capital Employed [ROCE] has a five-year change of +0.06 percentage points (FY2020 to FY2025).
  • By year, Return on Capital Employed [ROCE] came in at -54.67% in FY2024 (+20.60 pp), -75.27% in FY2023 (-11.87 pp), -63.40% in FY2022 (-13.27 pp) and -50.13% in FY2021 (+2.09 pp).
  • The Q2 2026 figure ranks as the highest quarterly Return on Capital Employed [ROCE] since Q4 2020.
  • The high point for year-over-year Return on Capital Employed [ROCE] in five years was Q3 2023 (a gain of 15.87 percentage points); the low point was Q3 2022 (a drop of 38.22 percentage points).
  • Per Business Quant data, the three quarters before Q2 2026 came in at -45.97% (Q1 2026), -52.34% (Q4 2025) and -53.37% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROCE (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 35.41%
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 17.52%
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 21.60%
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 4.65%
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 9.91%
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 17.37%
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -6.15%
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 11.32%
10 Iovance Biotherapeutics 3.74 Bn 2.45 Bn 73.44 Mn -27.18%
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 -27.18%
Jun 30, 2026 -37.03%
Mar 31, 2026 -45.97%
Dec 31, 2025 -52.34%
Sep 30, 2025 -53.37%
Jun 30, 2025 -50.83%
Mar 31, 2025 -48.88%
Dec 31, 2024 -47.71%
Sep 30, 2024 -50.01%
Jun 30, 2024 -55.77%
Mar 31, 2024 -63.01%
Dec 31, 2023 -65.23%
Sep 30, 2023 -62.53%
Jun 30, 2023 -60.99%
Mar 31, 2023 -63.62%
Dec 31, 2022 -77.68%
Sep 30, 2022 -78.39%
Jun 30, 2022 -63.72%
Mar 31, 2022 -54.19%
Dec 31, 2021 -48.01%
API Access

Iovance Biotherapeutics Return on Capital Employed [ROCE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=IOVA&period=max&api_key=YOUR_API_KEY